Pricing Log in Create free account

Caribou Biosciences, Inc. (CRBU) vs MindWalk Holdings Corp. (HYFT)

Caribou Biosciences, Inc. and MindWalk Holdings Corp. are both Biotechnology companies. Caribou Biosciences, Inc. and MindWalk Holdings Corp. are of similar size ($47.1M and $44.2M). Caribou Biosciences, Inc. grew revenue faster over the last twelve months: 1.60% against −27.0%. MindWalk Holdings Corp. has the higher net margin (−105.1% vs −1,085.0%) and the lower return on invested capital (−464.6% vs 0.00%). Across the 18 metrics below, Caribou Biosciences, Inc. leads on 9 and MindWalk Holdings Corp. on 9.

Valuation

Metric CRBU HYFT Biotechnology median
P/E n/m n/m 10.60
P/S 5.01 4.19 9.40
P/B 0.62 9.93 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.45 n/m 0.66
EV/Sales (5.03) 4.10 9.02
Earnings yield (234.09%) (24.76%) (32.88%)
Free cash flow yield (275.02%) (18.31%) (23.13%)

Profitability

Metric CRBU HYFT Biotechnology median
Gross margin 100.00% 60.81% 68.51%
Operating margin (1,140.55%) (103.99%) 0.00%
Net margin (1,085.00%) (105.06%) 0.00%
Free cash flow margin (985.95%) (76.79%) 0.00%
Return on equity (93.80%) (122.85%) (51.96%)
Return on assets (64.44%) (58.55%) (46.06%)
Return on invested capital 0.00% (464.59%) 0.00%

Growth

Metric CRBU HYFT Biotechnology median
Revenue growth (TTM) 1.60% (26.99%) 6.76%
EPS growth (last fiscal year) 3.64% 66.15% 29.88%
Revenue growth, 5-year CAGR (2.03%) (3.83%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU HYFT Biotechnology median
Debt to equity 0.00 0.43 0.00
Current ratio 4.97 1.84 4.97
Net debt to EBITDA 0.96 0.62 1.01

Dividend

Metric CRBU HYFT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBU HYFT Biotechnology median
Market cap 44.20m 47.12m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack